Abstract
Characterization of the complex molecular scaffold of the marine polyketide natural product phormidolide A represents a challenge that has persisted for nearly two decades. In light of discordant results arising from recent synthetic and biosynthetic reports, a rigorous study of the configuration of phormidolide A was necessary. This report outlines a synergistic effort employing computational and anisotropic NMR investigation, that provided orthogonal confirmation of the reassigned side chain, as well as supporting a further correction of the C7 stereocenter.
TOC
A combined computational and anisotropic NMR investigation provided orthogonal confirmation of the side chain configuration and support a further correction of the C7 stereocenter.

Phormidolide A (Fig. 1C) was isolated from the marine cyanobacterium Leptolyngbya sp. (strain ISB3NOV94–8A) and demonstrated mid-range toxicity in the brine shrimp model.1 Structurally, phormidolide A contains a 16-membered macrocycle linked to a pendant polyol side chain terminating in bromomethoxydiene; a signature motif shared with the related congeners phormidolide B, C and oscillariolide (see SI).2,3 The planar structure of phormidolide A was established from partial structures using 1H, 13C, COSY, multiplicity-edited HSQC, and HMBC NMR experiments.1 Additional confirmation for this assignment was provided by INADEQUATE and ACCORD-ADEQUATE data acquired on a 13C-enriched sample.1 The relative configuration of the tetrahydrofuran (THF) ring found in phormidolide A and the related congener oscillariolide was determined to be identical by conventional ROESY experiments.1 Additional insight pertaining to the relative configuration for the remainder of the molecule was obtained by the then new J-based configuration analysis (JBCA) method.4–8 Since that time, this method has been shown to be extremely robust except in unusual cases, such as relating the configuration from the 2- or 6-position of a tetrahydropyran moiety to an adjacent oxygenated stereogenic center.9 By analogy, the relative configuration from the C17 stereocenter to C16 of the neighboring tetrahydrofuran ring in phormidolide A was also shown to be problematic. In the case of phormidolide A, the configuration at C17 was assigned as anti relative to O16 based on a semi-quantitative utilization of the magnitude of 3JCH correlations from H17 to C15 and to CH3-37, respectively. This anti arrangement between H17 and O16 was corroborated by ROESY correlations from the CH3-37 to H18.1 In a recent report, synthetic work by the Paterson and Britton groups has demonstrated that the relative configuration at C17 should be assigned as syn relative to O16 (Fig 1B).10 Their work also showed that while the relative configuration between C17 and the remainder of the polyol chain (C21-C33) was assigned correctly in the original work, the reassignment at C17 inferred that the corresponding inversion of configuration at C21, C23, C25, C26, C27 and C29 was necessary.
Figure 1:
Schematic representation of phormidolide A stereochemical reassignment. (A) Previous incorrect structure, (B) synthetic revision of the side chain and (C) fully revised structure following computational and anisotropic NMR analysis disclosed in this work
Furthermore, in the original report, the absolute configuration at C7 was assigned as R through a set of variable temperature NMR experiments performed on a diacetonide- protected phormidolide.1 Since the relative configuration was established through extensive JBCA and NMR analyses, the absolute configuration of C7 was relayed to the THF ring, and to the remainder of the side chain to give the reported structure (Fig 1A). In 2016, the Gerwick group performed a complete biosynthetic gene cluster analysis on phormidolide that cast doubt on the 7R (or L-OH7) absolute configuration and therefore the stereochemistry of the natural product as a whole.11 To address this issue, the phormidolide A macrocycle was hydrolyzed and both the R and S α-methoxy-α-trifluoromethylphenylacetic acid (MTPA) esters were synthesized from the triacetonide derivative, and subsequent spectroscopic analysis initially appeared to agree with the original assignment (Fig S6). This apparent conundrum with the biogenetic data was resolved after noting a prior report from the Reynolds group,12 which suggested that the anomalous L-OH configuration (corresponding to the 7R) can indeed be catalytically generated from a type-B ketoreductase. Interestingly, a subsequent report from the Piel group on the genomic prediction and isolation of the leptolyngbyalides, a group of compounds closely related to the phormidolides, proposed not only the inversion of the configuration at C7 for phormidolide A, but also the remainder of the natural product.13
Following the Piel report, a structural analysis of the ROESY, E.COSY, and HSQMBC data utilized for the initial assignment suggested that the configuration at C7 could be inverted without significantly altering the reported correlations for phormidolide A. Interestingly, the molecular mechanics (MM) structure presented in the original report, as well as more recent MM optimizations for both macrocyclic C7 epimers, provided structures that would allow the logical explanation of all scalar and dipolar coupling data (Fig S7).
At this point, three configurations for phormidolide A have been proposed, namely the original assignment (Fig 1A),1 the Paterson/Britton assignment (Fig 1B)10 and the Piel assignment13. In light of our ongoing interest in the total synthesis of phormidolide A and the application of advanced NMR methods to structural/stereochemical assignment, we embarked on a multi-pronged approach focused on conclusively defining the configuration of phormidolide A, which is necessary to pin down an apparently dynamic target. Notably, we sought to leverage the advances in ab initio NMR methods,14 in conjunction with recently reported Residual Chemical Shift Anisotropy (RCSA) techniques,15–20 to independently verify the most likely structure for the natural product, as well as demonstrate the capability of these methods in deconvoluting a flexible and complex structure as challenging as phormidolide A.
Our first step towards verifying the stereochemical identity of phormidolide A was to investigate the apparent stereochemical mis-assignment at C17. DFT scalar coupling constant calculations of C17-epimers (R and S) of the C20-truncated sub-unit of phormidolide A (Fig 2) at GIAO-B3LYP21–24/6–31G(d)//M06–2X25/6–31+G(d,p), uncovered a reversal of the conventional 3JCH values for anti vs gauche configuration in these systems. The 17S configuration provided a single low energy conformation, stabilized by an OH-17 to O16 gauche hydrogen bond. The DFT-derived anti H17-CH3-37 3JCH coupling constant for this conformation was 3.3 Hz. Conversely, the 17R configuration provided two alternate conformations in a ~1:1 ratio, with OH-17 to O15 and OH-17 to O16 gauche hydrogen bonds, respectively. Whereas the former is in an anti-parallel conformation for H17-CH3-37 (with a 3JCH coupling constant of 3.9 Hz), the latter is in a gauche conformation (exhibiting a 3JCH of 4.3 Hz). Reanalysis of the original spectroscopic data with modern data processing tools revealed a coupling of 4.1 Hz, which is in seamless agreement with the averaged DFT prediction for the 17R conformers (Fig 2). This anomalous result obfuscates the conclusive assignment of C17 through empirical JBCA, and thus requires more advanced analytical techniques to verify the configuration, as reported here.
Figure 2:
C20-trucated phormidolide A C17-epimers (S and R) – complete macrolide not shown – that were utilized for computational investigation of the relative configuration of C17 with respect to the THF ring.
Encouraged by the insight provided by ab initio methods, and recalling the uncertainty surrounding the assignment of 7R in the original report, DP4 calculations of the 1H and 13C chemical shifts of the two truncated macrocycle C7-epimers of phormidolide A (Fig S11) were undertaken.26 Geometries, shifts and conformer energies were calculated using DFT conditions found to be optimal in recent studies.27,28 The statistical model used was also tailored to the particular computational conditions. DP4 calculations suggested a 100% probability that the original assignment (7R) should be inverted, i.e. the 7S configuration. This conclusion was further supported by the calculated chemical shifts, where initially large prediction errors were significantly reduced in the reassigned structure (Fig 3).
Figure 3:
NMR shift DFT GIAO prediction errors (in absolute value mode) after internal scaling for 1H (top) and 13C (bottom). Geometries: B3LYP/6–31G**; shifts: mPW1PW91/6–311G*; conformer energies: M06–2X/def2-TZVP.
In addition, DFT calculations of 3JHH, 2JCH, and 3JCH coupling constants (GIAO-B3LYP/6–31G(d)//M06–2X/6–31+G(d,p)) and 13C NMR chemical shifts (GIAO-mPW1PW9129/6–311+G(2d,p) //M06–2X/6–31+G(d,p)), also indicated the 7S assignment (Fig 4). A recent report has demonstrated the utility of long-range J-coupling constants for diastereomeric analysis.30 Due to the computational demands of modelling such a highly flexible molecule, the models were truncated at C24 with only eight isomers considered. These isomers corresponded to isomeric permutations at the C7, C17 and C21/C23 stereocenters. In this context, SRS would mean a 7S, 17R and 21S configuration, respectively – with the THF fragment configuration remaining unchanged as shown in Fig 1A (n.b.: this notation also corresponds to 21S/23R, which are considered as a pair in each model and inverted simultaneously). The Mean Absolute Error (MAE) of experimental vs. DFT-derived scalar coupling and chemical shift values (up to C21 but excluding sp2 carbons due to errors associated with the DFT functional used)31,32 not only favor the 7S configuration but also the 17R configuration (Fig 1C), with values of 0.84 and 1.22, respectively (compared to 0.93 and 1.36 computed for the SSR configuration). Interestingly, including the sp2 carbon chemical shifts (previously excluded) in the statistical analysis also favor the SRS configuration (Fig S13).
Figure 4:
Bar charts of Mean Absolute Error (MAE) analysis of Expt. vs. DFT calculated J coupling constants (blue) and 13C NMR chemical shift values (red). The MAE from both analyses favor the stereochemical revision of phormidolide A to the structure shown in Fig 1C, with the smallest values of 0.84 and 1.22, respectively.
As a final check on the revised configuration of phormidolide A (Fig 1C), we further embarked on an orthogonal structure verification process – leveraging anisotropic NMR parameters to generate an unbiased orthogonal evaluation of structural accuracy. Anisotropic NMR data, including Residual Dipolar Coupling (RDC) and Residual Chemical Shift Anisotropy (RCSA), have developed into powerful parameters for verification of proposed molecular constitution, and thereby increase confidence in assigned structures.15,17,18,33–39 In particular, 13C NMR chemical shift changes due to Residual Chemical Shift Anisotropy (RCSA) in appropriate liquid crystalline alignment media provide information on the relative orientations of nuclear chemical shielding tensors of the molecule that provides detailed information on molecular constitution and configuration that can be applied to molecules of even moderate flexibility. The eight diastereomeric phormidolide A configurations (RRR, RRS, RSR, RSS, SSR, SRS, SSR and SSS), truncated at C24, were also used for anisotropic NMR evaluation. Due to the moderate flexibility of these diastereomers (SI), which resulted in the generation of multiple conformations with >1 % Boltzmann populations, theoretically determined conformer electronic energies were used as additional constraints in the single-tensor singular value decomposition (SVD) analysis40 of the proposed structures. This approach potentially minimizes SVD overfitting of the comparatively sparse RCSA dataset. The superimposed conformations of the SRS configuration (Fig S14) demonstrates that single-tensor SVD analysis can be applied to these moderately flexible systems. To verify the Paterson/Piel revised side-chain configuration (and thus the revised stereochemistry of phormidolide A, Fig 1C, in general), RCSA data up to C22, including the diastereotopic methyl groups C39/C40, were also used for SVD analysis (summarized in Fig 5). Clearly, the SRS configuration agrees best with the measured RCSA data giving a Q-factor of 0.190, while the nearest configuration SRR gave a Q-factor of 0.418. A revision of phormidolide A to the SRS structure (i.e. 7S, 17R, 21/23S in Fig 1C) is thus warranted.
Figure 5:
(A) Bar charts of Q-factors of isomeric phormidolide A structures, involving permutational stereo-inversion at C7, C17 and C21/C23 (highlighted inset, Fig. 5(B)), providing further evidence for the structural revision of phormidolide A to SRS. (B) Correlation plot of experimental. RCSAs vs. theoretically calculated RCSAs of the revised structure of phormidolide A (7S, 17R and 21S/23R, also termed SRS for C7, C17 and C21 stereocenters), showing in the inset a Q-factor of 0.190 and the SRS C24-truncated phormidolide A fragment.
In this work, we report the synergistic application of ab initio NMR prediction methods in combination with anisotropic NMR parameters to establish the likely structure of phormidolide A. Through the confluence of three advanced techniques previously unavailable, we highlight that the reassigned relative configuration between the THF core and the side chain was correctly formulated by Paterson/Britton, while independently confirming the stereochemical reassignment of 7R to the epimeric 7S configuration as proposed by Piel, but correcting the relative configuration to the THF ring. Notably, these results resolve the stereochemical discrepancies extant between the original isolation report, the Paterson/Britton and subsequent Piel reassignments with the biogenetic data presented by the Gerwick group. This work serves to demonstrate that without these analytical advancements over the last two decades, a complex structure such as phormidolide A would have been difficult to define. Work on the total synthesis of phormidolide A is on-going, which will provide a definitive proof-of-structure as a final verification of the stereochemical reassignments proposed for this fascinating yet problematic natural product.
Supplementary Material
Acknowledgements
IEN acknowledges Parastoo Azadi and Christian Heiss from the University of Georgia for NMR spectroscopy (grant DE-SC0015662 to PA). KLA acknowledges Sebastian Rohrer from University of California, San Diego, for wet chemistry assistance, and financial support from NIH T32 GM067550. WHG acknowledges NIH GM107550. NYSL acknowledges the Woolf Fisher Trust for financial support. KE thanks Leverhulme Trust and Isaac Newton Trust for financial support.
Footnotes
There are no conflicts to declare.
† Footnotes relating to the title and/or authors should appear here.
Notes and references
- 1.Williamson RT, Boulanger A, Vulpanovici A, Roberts MA and Gerwick WH, J. Org. Chem, 2002, 67, 7927–7936. [DOI] [PubMed] [Google Scholar]
- 2.Lorente A, Gil A, Fernández R, Cuevas C, Albericio F and Álvarez M, Chem. - A Eur. J, 2015, 21, 150–156. [DOI] [PubMed] [Google Scholar]
- 3.Murakami M, Matsuda H, Makabe K and Yamaguchi K, Tetrahedron Lett, 1991, 32, 2391–2394. [Google Scholar]
- 4.Williamson RT, Marquez BL, Barrios Sosa AC and Koehn FE, Magn. Reson. Chem, 2003, 41, 379–385. [Google Scholar]
- 5.Cimino P, Bifulco G, Evidente A, Abouzeid M, Riccio R and Gomez-Paloma L, Org. Lett, 2002, 4, 2779–2782. [DOI] [PubMed] [Google Scholar]
- 6.Matsumori N, Kaneno D, Murata M, Nakamura H and Tachibana K, J. Org. Chem, 1999, 64, 866–876. [DOI] [PubMed] [Google Scholar]
- 7.Molinski TF and Morinaka BI, Tetrahedron, 2012, 68, 9307–9343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Bifulco G, Dambruoso P, Gomez-Paloma L and Riccio R, Chem. Rev, 2007, 107, 3744–3779. [DOI] [PubMed] [Google Scholar]
- 9.Wakamiya Y, Ebine M, Matsumori N and Oishi T, J. Am. Chem. Soc, 2020, 142, 3472–3478. [DOI] [PubMed] [Google Scholar]
- 10.Lam NYS, Muir G, Challa VR, Britton R and Paterson I, Chem. Commun, 2019, 55, 9717–9720. [DOI] [PubMed] [Google Scholar]
- 11.Bertin MJ, Vulpanovici A, Monroe EA, Korobeynikov A, Sherman DH, Gerwick L and Gerwick WH, ChemBioChem, 2016, 17, 164–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Bonnett SA, Whicher JR, Papireddy K, Florova G, Smith JL and Reynolds KA, Chem. Biol, 2013, 20, 772–783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Helfrich EJN, Ueoka R, Dolev A, Rust M, Meoded RA, Bhushan A, Califano G, Costa R, Gugger M, Steinbeck C, Moreno P and Piel J, Nat. Chem. Biol, 2019, 15, 813–821. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Lauro G and Bifulco G, European J. Org. Chem, 2020, 1–14. [Google Scholar]
- 15.Liu Y, Saurí J, Mevers E, Peczuh MW, Hiemstra H, Clardy J, Martin GE and Williamson RT, Science 2017, 356, 5349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Liu Y, Cohen RD, Gustafson KR, Martin GE and Williamson RT, Chem. Commun, 2018, 54, 4254–4257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Ndukwe IE, Brunskill A, Gauthier DR, Zhong YL, Martin GE, Williamson RT, Reibarkh M and Liu Y, Org. Lett, 2019, 21, 4072–4076. [DOI] [PubMed] [Google Scholar]
- 18.Ndukwe IE, Wang X, Pelczer I, Reibarkh M, Williamson RT, Liu Y and Martin GE, Chem. Commun, 2019, 55, 4327–4330. [DOI] [PubMed] [Google Scholar]
- 19.Liu Y, Navarro-Vázquez A, Gil RR, Griesinger C, Martin GE and Williamson RT, Nat. Protoc, 2019, 14, 217–247. [DOI] [PubMed] [Google Scholar]
- 20.Nath N, Schmidt M, Gil RR, Williamson RT, Martin GE, Navarro-Vázquez A, Griesinger C and Liu Y, J. Am. Chem. Soc, 2016, 138, 9548–9556. [DOI] [PubMed] [Google Scholar]
- 21.Stephens PJ, Devlin FJ, Chabalowski CF and Frisch MJ, J. Phys. Chem, 1994, 98, 11623–11627. [Google Scholar]
- 22.Vosko SH, Wilk L and Nusair M, Can. J. Phys, 1980, 58, 1200–1211. [Google Scholar]
- 23.Lee C, Yang W and Parr RG, Phys. Rev. B, 1988, 37, 785–789. [DOI] [PubMed] [Google Scholar]
- 24.Becke AD, J. Chem. Phys, 1993, 98, 5648–5652. [Google Scholar]
- 25.Zhao Y and Truhlar DG, Theor. Chem. Acc, 2008, 120, 215–241. [Google Scholar]
- 26.Smith SG and Goodman JM, J. Am. Chem. Soc, 2010, 132, 12946–12959. [DOI] [PubMed] [Google Scholar]
- 27.Ermanis K, Parkes KEB, Agback T and Goodman JM, Org. Biomol. Chem, 2019, 17, 5886–5890. [DOI] [PubMed] [Google Scholar]
- 28.Howarth A, Ermanis K and Goodman JM, Chem. Sci, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Adamo C and Barone V, J. Chem. Phys, 1998, 108, 664–675. [Google Scholar]
- 30.Koos MRM, Navarro‐Vázquez A, Anklin C and Gil RR, Angew. Chemie, 2020, 132, 3966–3969. [DOI] [PubMed] [Google Scholar]
- 31.Lodewyk MW, Siebert MR and Tantillo DJ, Chem. Rev, 2012, 112, 1839–1862. [DOI] [PubMed] [Google Scholar]
- 32.Sarotti AM and Pellegrinet SC, J. Org. Chem, 2009, 74, 7254–7260. [DOI] [PubMed] [Google Scholar]
- 33.Ibáñez de Opakua A, Klama F, Ndukwe IE, Martin GE, Williamson RT and Zweckstetter M, Angew. Chemie Int. Ed, 2020, 1–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Milanowski DJ, Oku N, Cartner LK, Bokesch HR, Williamson RT, Saurí J, Liu Y, Blinov KA, Ding Y, Li X-C, Ferreira D, Walker LA, Khan S, Davies-Coleman MT, Kelley JA, McMahon JB, Martin GE and Gustafson KR, Chem. Sci, 2018, 9, 307–314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mevers E, Saurí J, Liu Y, Moser A, Ramadhar TR, Varlan M, Williamson RT, Martin GE and Clardy J, J. Am. Chem. Soc, 2016, 138, 12324–12327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Schwab M, Schmidts V and Thiele CM, Chem. - A Eur. J, 2018, 24, 14373–14377. [DOI] [PubMed] [Google Scholar]
- 37.Thiele CM, European J Org. Chem, 2008, 2008, 5673–5685. [Google Scholar]
- 38.de Melo Sousa CM, Giordani RB, de Almeida WAM, Griesinger C, Gil RR, Navarro-Vázquez A and Hallwass F, Magn. Reson. Chem, 2019, 1–8. [DOI] [PubMed] [Google Scholar]
- 39.Navarro-Vázquez A, Gil RR and Blinov K, J. Nat. Prod, 2018, 81, 203–210. [DOI] [PubMed] [Google Scholar]
- 40.Losonczi JA, Andrec M, Fischer MW and Prestegard JH, J. Magn. Reson, 1999, 138, 334–342. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





